FDA recall, , Moderate risk
Accord Healthcare Levothyroxine Sodium Tablets
Levothyroxine Sodium Tablets are subpotent.
Summary by Recall Canary from the FDA notice
What happened
Accord Healthcare, Inc., of Raleigh, North Carolina, recalled Levothyroxine Sodium Tablets, USP, in multiple strengths because the drug is subpotent. The recall began on August 6, 2026, and was added to the FDA's Enforcement Report on August 21, 2026. The tablets were distributed nationwide within the United States.
What to do
We don't have product-specific instructions for this recall. FDA's general advice for medicine recalls:
- Check the FDA or company notice for instructions specific to this product.
- Ask your pharmacist or doctor whether your lot is affected and what to do.
Is yours affected?
Match your product and all the details in one listed combination.
An NDC (National Drug Code) is usually printed on the drug's label.
Levothyroxine Sodium Tablets, USP
- Lot code
- 2026
- Strength
- 150 mcg
- NDC
- 16729-455-17
- Strength
- 100 mcg
- NDC
- 16729-451-15
- 16729-451-17
- Strength
- 200 mcg
- NDC
- 16729-457-15
- 16729-457-17
- Strength
- 137 mcg
- NDC
- 16729-454-15
- 16729-454-17
- Strength
- 25 mcg
- NDC
- 16729-447-17
- Strength
- 112 mcg
- NDC
- 16729-452-17
- Strength
- 300 mcg
- NDC
- 16729-458-15
- Strength
- 50 mcg
- NDC
- 16729-448-17
- Strength
- 175 mcg
- NDC
- 16729-456-15
- 16729-456-17
- Strength
- 125 mcg
- NDC
- 16729-453-17
- Strength
- 75 mcg
- NDC
- 16729-449-17
- Strength
- 88 mcg
- NDC
- 16729-450-17
Recall details
- Company began the recall
- Sold in
Nationwide within the United States
- Company
- ACCORD HEALTHCARE, INC.Raleigh, North Carolina
- Hazard
- Wrong drug strength
- Risk
Moderate risk
Taking it may cause short-term health problems, or ones that treatment can reverse. Serious harm is unlikely.
FDA Class II recall · How risk is rated
- Event ID
- 99584
- Recall numbers
- D-0775-2026 to D-0786-2026
All recalls from ACCORD HEALTHCARE, INC.
Timeline
FDA's Enforcement Report is its public list of recalls; FDA adds a recall when it posts it and publishes the list weekly.
Company began the recall
Added to FDA's Enforcement Report · Classified by FDA
Listed on Recall Canary
In FDA's weekly enforcement report
Summary updated
